Inflammation in Obesity-Related HFpEF
Most Cited Paper
in Heart Failure Treatment and Management
18 Months Post-Publication
Class of 2026
“Inflammation in Obesity-Related HFpEF”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026/
Topics
Obesity-related HFpEF · Inflammation · C-reactive protein · Semaglutide · GLP-1 receptor agonist · Body weight reduction · STEP-HFpEF trial · STEP-HFpEF trial · STEP-HFpEF DM trial · Randomized controlled trial · Placebo-controlled trial · KCCQ Clinical Summary Score · 6-minute walk distance · Hierarchical composite endpoint · Worsening heart failure events · health status · Functional impairment · exercise function · Body mass index · Biomarker stratification · Pooled analysis · Weight loss and inflammation relationship · baseline characteristics · Type 2 diabetes · Obesity · Cardiometabolic disease · Treatment effect heterogeneity · P interaction analysis · Clinical trial endpoints · Anti-inflammatory effect of semaglutide
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459